Search

Search results

488 results found

Treatment-related harms: what was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review.

Mhaskar, Rahul S, Tea Reljic, Hesborn Wao, Ambuj Kumar, Branko Miladinovic, and Benjamin Djulbegovic. 2014. “Treatment-Related Harms: What Was Planned and What Was Reported? National Cancer Institute’s Co-Operative Group Phase III Randomized Controlled Trials: A Systematic Review.”. Journal of Clinical Epidemiology 67 (3): 354-6.

Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review.

Mhaskar, Rahul, Ambuj Kumar, Madhusmita Behera, Mohamed A Kharfan-Dabaja, and Benjamin Djulbegovic. 2009. “Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review.”. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 15 (8): 893-902.

ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy.

Hashmi, Hamza, Ambuj Kumar, Mohamed A Kharfan-Dabaja, Pashna N Munshi, Yoshihiro Inamoto, Zachariah DeFilipp, Bhagirathbhai Dholaria, et al. 2024. “ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma After Failure of Chimeric Antigen Receptor T Cell Therapy.”. Transplantation and Cellular Therapy.